Sunday, February 08, 2026 | 07:28 AM ISTहिंदी में पढें
Oxygenta Pharmaceutical Ltd
Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter Ended December 31 2025.2. Limited Review Report For The Quarter Ended December 31 2025.3. Any Other Business With The Permission Of The Chair.
06:01 PM, 30th Jan 2026
Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve 1. Un-audited Financial results for the quarter ended December 31 2025.2. Limited Review Report for the quarter ended December 31 2025.3. Any other business with the permission of the Chair.